Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$9.34M Sell
67,509
-1,257
-2% -$198K 0.08% 200
2015
Q2
$10.6M Buy
68,766
+3,254
+5% +$521K 0.09% 202
2015
Q1
$10.5M Buy
65,512
+417
+0.6% +$65.7K 0.09% 210
2014
Q4
$10.4M Sell
65,095
-3,127
-5% -$487K 0.09% 209
2014
Q3
$9.58M Sell
68,222
-5,968
-8% -$779K 0.09% 222
2014
Q2
$8.78M Buy
74,190
+29,755
+67% +$3.44M 0.08% 221
2014
Q1
$5.48M Sell
44,435
-10,229
-19% -$1.24M 0.08% 221
2013
Q4
$6.24M Sell
54,664
-6,020
-10% -$685K 0.09% 215
2013
Q3
$6.79M Sell
60,684
-15,487
-20% -$1.68M 0.12% 192
2013
Q2
$7.51M Buy
+76,171
New +$7.9M 0.14% 176

Other funds holding AMGN

City National Bank's AMGN Position: Q3 2015 in Review

City National Bank reduced its Amgen (AMGN) stake by 1.8% in Q3 2015, selling an estimated $198K and leaving 67,509 shares worth $9.34M. The position accounts for 0.08% of the portfolio, ranked #200.

City National Bank first reported a position in AMGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $10.6M in Q2 2015. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • City National Bank held 67,509 shares of Amgen worth $9.34M as of Q3 2015.
  • City National Bank sold 1,257 Amgen shares in Q3 2015, an estimated $198K.
  • Amgen made up 0.08% of City National Bank's portfolio in Q3 2015, its #200 holding.
  • City National Bank first reported a position in Amgen in Q2 2013 and has held it in 10 quarters since.
  • City National Bank's Amgen position peaked at $10.6M in Q2 2015.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.